...Ark first applied for approval in 2005 after mid-stage trial results, but was asked by regulators to perform a larger trial. AstraZeneca: The Anglo-Swedish drugs maker said that it hopes to sell a nasal spray flu vaccine in Europe; the product is already available...

...the courts) including a recent challenge by AstraZeneca. The two settled, which allows Teva to sell a generic version of AstraZeneca's asthma treatment Pulmicort Respules until 2019, when the latter expects its patent to expire. The strong track record gives...

...proprietary technology creates a highly effective engagement experience, as demonstrated by the results we achieved for AstraZeneca through a turnkey direct mail application that connected physicians to a protected brand Web site." Kyp Systems, Inc. is the...

...for a recovery in DRAM contract prices. Across the pond in Europe, pharmaceutical firms were dominating headlines, with AstraZeneca (AZN) rallying 1.6% after the company said it applied for European approval for a flu vaccination product. In addition, automakers...

...activity and stronger safeguards on the “revolving door” between government and business. While Chris Brinsmead, president of AstraZeneca and the ABPI, was giving evidence to the inquiry, he was challenged by the panel’s chairman. Labour MP Dr Tony Wright,...

...the spread of influenza around the world," said Dr. Alex Zukiwski, chief medical officer of MedImmune, a subsidiary of AstraZeneca. The nasal spray is already marketed in the United States under the trade name FluMist. It was approved by the U.S. Food and...

...AstraZeneca said that it has applied for European approval for a flu vaccination. Additionally, Porsche (DE:PAH003: news , chart , profile ) , down 0.9%, said that it will raise its stake in Volkswagen to 50.76%. Shares in British clothing chain operator...

...has recently strengthened its portfolio by acquiring strategic products and subsidiaries in particular regions from rivals AstraZeneca and Bristol-Myers Squibb . Bankers, keen for important mandates at a time when deal flow has been drying up, predict a return...

...unit will work in concert with Recipharm’s sterile manufacturing facility in Monts, also in France, that was purchased from AstraZeneca last July. The firm plans to use the additional capacity to diversify its product range and client base. In an interview...

...education. And at the prodding of Sen. Chuck Grassley, who's among those leading the charge for disclosure regulation, AstraZeneca pledged to start posting payments for professional meetings and patient advocacy groups on its company website, and several other...